Top Markets
#1 Derive Derive +32.97%
#2 Cross Cross +20.16%
#3 Geodnet Geodnet +12.50%
#4 Gama Token Gama Token +9.20%
#5 Biconomy Biconomy +9.08%
#6 Steakhouse ETH Morpho Vault Steakhouse ETH Morpho Vault +7.14%
#7 Quantum Resistant Ledger Quantum Resistant Ledger +6.82%
#8 The Bitcoin Bull The Bitcoin Bull +6.60%
#9 Cap Cap +6.32%
#10 OVERTAKE OVERTAKE +6.30%
Coin of the day
Derive Derive
Innstillinger
Språk
NORSK
Valuta
USD
Tema
Creative Medical Technology Holdings, Inc. Creative Medical Technology Holdings, Inc.

Creative Medical Technology Holdings, Inc.

CELZ
Rangering i aksjer #35972
Creative Medical Technology Holdings, Inc., a biotechnology firm based in... Creative Medical Technology Holdings, Inc., a biotechnology firm based in Phoenix, Arizona, specializes in advancing adult stem cell treatments. The company's core focus spans several medical fields, including immunology, urology, orthopedics, and neurology. Among its therapeutic offerings are CaverStem, designed to address erectile dysfunction; FemCelz, which aims to restore genital sensitivity and alleviate dryness; StemSpine, developed to treat chronic lower back pain; ImmCelz, intended for stroke patients; and OvaStem, a solution for female infertility.
Aksjekurs
$1.25
Sist synkronisert: 2026-08-14
Markedsverdi
$3.21M
Endring (1 dag)
0.40%
Endring (1 år)
-60.10%
Land
US
Handel Creative Medical Technology Holdings, Inc. (CELZ)

Kategori

Healthcare
Inntekter for Creative Medical Technology Holdings, Inc. (CELZ)
Inntekter i 2026 TTM: 0
Ifølge Creative Medical Technology Holdings, Inc. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Creative Medical Technology Holdings, Inc. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
$5.27B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
$1.95B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
- -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
$3.01B -
BE